Search

everythinglearnresearchcommunity

for

Search:↓

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Metformin promotes hair growth by affecting cell growth and protein signaling related to hair growth.

CIPK13 and CIPK18 genes are crucial for root hair growth in plants.

Finasteride helps female-pattern hair loss.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The STRIPAK complex is crucial for skin cell organization and creating a functional skin barrier.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Green tea compound EGCG helps mink hair follicles grow by affecting certain cell growth pathways.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

The genetic variant studied does not affect PCOS symptoms in Kashmiri women.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Peach kernel extract may promote hair growth by boosting cell growth in hair follicles.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.